According to univariate analysis, those patients with strong TLR1 tumor expression had better overall disease-specific survival than did patients whose TLR1 expression was low or negative (median survival time 2.40 (95% CI 1.78–3.01; n = 154) years and 1.27 (95% CI 0.00–2.87) years; log-rank with Sidak adjustment for multiple comparisons, p = 0.0439) (Fig 2). Here, TLR1 is linked to neoplasm.